arrow
D

Dylan M. Marchione

pennsylvania medicine
H指数:21
被引数:4,324

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML

AGILE研究中,阿扎胞苷联合伊沃西登ib与安慰剂在 Newly Diagnosed IDH1-mutated AML中的长期结果

2025-07-280
OAAI
Single-Cell Proteogenomic Analysis of Clonal Evolution in Patient-Derived Xenograft Models of AML Treated with IDH Inhibitors

患者来源的AML异种移植模型中IDH抑制剂治疗下克隆演变的单细胞蛋白质组学分析

BLOOD
IF23.1
2024-11-050
PRE
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

ivosidenib治疗突变型IDH1复发/难治性骨髓增生异常综合征患者的最终1期亚研究结果

2024-08-134
OAAI
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia
2023-04-0420
OA
Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients
2020-12-0451
OAAI
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2020-12-0153
OAAI
Human chimeric antigen receptor macrophages for cancer immunotherapy

用于癌症免疫治疗的人嵌合抗原受体巨噬细胞

2020-03-23910
OAAI
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis
2019-03-19245
OAAI
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
2017-01-09219
OAAI